GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Source Last Updated
PSICQUIC March 30, 2022
Displaying entries 1151 - 1175 of 4050 in total
Antibody Patient Onset (days) Symptom GlyTouCan ID ▲ Arbitrary Fluorescence Units (AFU)
IgA Patient 2 24 mild
G22768VO
1132
IgG Patient 2 15 mild
G22768VO
93
IgG Patient 2 24 mild
G22768VO
96
IgM Patient 2 15 mild
G22768VO
464
IgM Patient 2 24 mild
G22768VO
489
IgA Patient 2 3 mild
G22768VO
1272
IgG Patient 2 3 mild
G22768VO
122
IgM Patient 2 3 mild
G22768VO
679
IgA Patient 3 -180 mild
G22768VO
272
IgA Patient 3 11 mild
G22768VO
443
IgG Patient 3 -180 mild
G22768VO
44
IgM Patient 3 -180 mild
G22768VO
92
IgA Patient 3 4 mild
G22768VO
461
IgG Patient 3 11 mild
G22768VO
49
IgG Patient 3 4 mild
G22768VO
46
IgM Patient 3 11 mild
G22768VO
196
IgM Patient 3 4 mild
G22768VO
194
IgA Patient 4 12 mild
G22768VO
351
IgG Patient 4 12 mild
G22768VO
61
IgM Patient 4 12 mild
G22768VO
139
IgA Patient 1 10 moderate
G24432YB
352
IgA Patient 1 22 moderate
G24432YB
297
IgA Patient 1 6 moderate
G24432YB
279
IgG Patient 1 10 moderate
G24432YB
21
IgG Patient 1 22 moderate
G24432YB
21

About Release Notes Help Feedback

International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.1.0

Last updated: December 9, 2024